Approximately 80% of patients in intensive care showed clinical improvement in gram-positive bacterial infections after treatment with linezolid, based on data from more than 300 individuals.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It ...

Chronic antibiotic suppression may be a reasonable strategy in patients with periprosthetic joint infections, with reoperation successfully avoided in most patients with hip and gram-positive ...

The increasing prevalence of antibiotic resistance, when infectious bacteria evolve to evade drugs designed to control them, is a pressing public health concern. Each year two million Americans ...

In a large cohort, long-acting lipoglycopeptides (laLGPs) demonstrated comparable effectiveness to standard-of-care antibiotics for step-down treatment of serious Gram-positive bacterial infections in ...

A potent new antibiotic intermediate from Streptomyces coelicolor is 100 times stronger than methylenomycin A against drug-resistant bacteria.

Clostridium perfringens is a spore-forming bacteria that can function without oxygen (anaerobic bacteria). These gram-positive bacteria are typically found in human and animal intestines. Bacteria are ...

Mouths are filthy, harboring the second largest microbiome of the human body. Some bacteria can help break down food, among other responsibilities; other bacteria can travel into the mouth on food, ...

In a recent study, researchers demonstrated that a novel compound could treat flesh-eating Gram-positive bacterial infections in mice, potentially offering a new class of antibiotics. Researchers at ...